Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/25 20:35 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | 2 | S.dm | -422 | 13.62 | 0 | -31 | 23 | D | |||||||||||||||
1/6/25 20:34 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | 2 | S.dm | -1,113 | 13.71 | 0 | -81 | 81 | D | |||||||||||||||
1/6/25 20:19 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | 1 | S.d | -166 | 14.92 | 0 | -11 | 9 | D | |||||||||||||||
1/8/24 18:14 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Astle Christopher | DE | O | SVP,CFO | 2 | S.dm | -73 | 10.57 | 0 | -7 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |